Sugi Predict

Sugi Predict / Compounds / SCHEMBL2798568

SCHEMBL2798568

SCHEMBL2798568

O=Cc1ccc2c(c1)OC=CO2

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ PTGS2 P35354 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ CYP2A6 P11509 6/20 0.39
▸ TSHR P16473 1/20 0.38
▸ ALDH1A3 P47895 2/20 0.37
▸ ALDH3A1 P30838 1/20 0.37
▸ ALDH5A1 P51649 2/20 0.36
▸ ABAT P80404 2/20 0.36
▸ AOX1 Q06278 1/20 0.34
▸ TRIM24 O15164 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TRIM33 Q9UPN9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23775788 0.76 ALDH1A1 (0.59) ALDH1A1HSD17B10TDP1PTGS2KDM4E
SCHEMBL5515460 0.72 ALDH1A1 (0.42) ALDH1A1HSD17B10TDP1PTGS2KDM4E
SCHEMBL1749249 0.72 ALDH1A1 (0.46) ALDH1A1HSD17B10TDP1PTGS2KDM4E
SCHEMBL5314335 0.72 ALDH1A1 (0.42) ALDH1A1HSD17B10TDP1PTGS2KDM4E
Piperonal SCHEMBL29411164 0.71 ALDH1A1 (1.00) ALDH1A1HSD17B10TDP1KDM4ERAB9A
SCHEMBL6489263 0.71 ALDH1A1 (0.53) ALDH1A1HSD17B10TDP1PTGS2KDM4E
SCHEMBL210494 0.71 ALDH1A1 (0.77) ALDH1A1HSD17B10TDP1KDM4ERAB9A
SCHEMBL30576999 0.71 ALDH1A1 (0.77) ALDH1A1HSD17B10TDP1KDM4ERAB9A
SCHEMBL23501057 0.71 ALDH1A1 (0.53) ALDH1A1HSD17B10TDP1PTGS2KDM4E
Piperonal SCHEMBL29318 0.71 ALDH1A1 (1.00) ALDH1A1HSD17B10TDP1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12454502-B2 Synthesis of deuterated aldehydes ARIZONA BOARD OF REGENTS ON BEHALF OF ATHE UNIVERSITY OF ARIZONA (US) 2025-10-28 — — US disclosed
US-20220356139-A1 SYNTHESIS OF DEUTERATED ALDEHYDES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2022-11-10 — — US disclosed
CN-114507175-A Novel inhibitors of hypnotic proteins alpha and beta 维沃里翁治疗股份有限公司 2022-05-17 — — CN disclosed
CN-109195947-B Novel inhibitors of hypnotic proteins alpha and beta 维沃里翁治疗股份有限公司 2022-03-04 — — CN disclosed
WO-2021045879-A1 SYNTHESIS OF DEUTERATED ALDEHYDES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-03-11 — — WO disclosed
CN-106604731-A Anticancer compounds targeting RAL GTPase and methods of using the same 科罗拉多大学董事会法人团体 2017-04-26 — — CN disclosed
US-8524738-B2 Quinolinones and quinoxalinones as antibacterial composition TOYAMA CHEMICAL CO., LTD. (JP) 2013-09-03 — — US disclosed
US-8329694-B2 Quinoxalinones as antibacterial composition TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 — — US disclosed
US-20120214990-A1 QUINOLINONES AND QUINOXALINONES AS ANTIBACTERIAL COMPOSITION TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-08-23 — — US disclosed
EP-2468743-A1 Nitrogen-containing bicyclic compounds useful as antibacterial agents Toyama Chemical Co., Ltd. (JP) 2012-06-27 — — EP disclosed
US-20060122234-A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors ARGENTA DISCOVERY LIMITED 2006-06-08 — — US disclosed
CN-1684957-A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors ARGENTA DISCOVERY LTD (GB) 2005-10-19 — — CN disclosed
EP-1525199-A1 SUBSTITUTED THIENYL-HYDROXAMIC ACIDS AS HISTONE DEACETYLASE INHIBITORS Argenta Discovery Limited (GB) 2005-04-27 — — EP disclosed
WO-2004013130-A1 SUBSTITUTED THIENYL-HYDROXAMIC ACIDS AS HISTONE DEACETYLASE INHIBITORS ARGENTA DISCOVERY LIMITED (GB) 2004-02-12 — — WO disclosed
US-6365605-B1 ADMINISTERING D.SUB.3 RECEPTOR LIGAND FOR THERAPY OF CONDITIONS SELECTED FROM DEPRESSION, SCHIZOPHRENIA, PSYCHOSES, PARKINSONS'S DISEASE, MEMORY DISORDERS, AND DISORDERS ASSOCIATED WITH DRUG ABUSE LES LABORATOIRES SERVIER (FR) 2002-04-02 — — US disclosed
US-6326377-B1 PSYCHOLOGICAL DISORDERS THERAPY ADIR ET COMPAGNIE (FR) 2001-12-04 — — US disclosed
EP-0887350-B1 Chromene derivatives, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 2001-08-22 — — EP disclosed
US-6090837-A PSYCHOLOGICAL DISORDERS ADIR ET COMPAGNIE (FR) 2000-07-18 — — US disclosed
EP-0887350-A1 Chromene derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1998-12-30 — — EP disclosed
US-4613601-A (1-benzodioxin-6-ylmethyl)-4-substituted piperazines having antipsychotic activity ADIR, S.A.R.L. (FR) 1986-09-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12454502-B2 Synthesis of deuterated aldehydes ADH1C, ADH1A, CBR1 ALDH1A1 8/4885HSD17B10 120/4885TDP1 1489/4885
US-20120214990-A1 QUINOLINONES AND QUINOXALINONES AS ANTIBACTERIAL COMPOSITION NQO2, ASNS, NDUFS1 ALDH1A1 3142/4885HSD17B10 2145/4885TDP1 4009/4885
US-20060122234-A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors HDAC1, HDAC11, HDAC2 ALDH1A1 291/4885HSD17B10 55/4885TDP1 841/4885
US-20220356139-A1 SYNTHESIS OF DEUTERATED ALDEHYDES ADH1C, ADH1A, CBR1 ALDH1A1 8/4885HSD17B10 120/4885TDP1 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.